首页>
外国专利>
Multimodal drug diagnostic evaluation of brain health
Multimodal drug diagnostic evaluation of brain health
展开▼
机译：脑健康的多模式药物诊断评估
展开▼
页面导航
摘要
著录项
相似文献
摘要
A regulatory agency approved drug, biologic, vitamin, ingredient, or that is capable of binding molecular specificity or providing a well-characterized molecular effect to a mammalian host (including human) A single diagnostic administration of a chemical agent, such as other chemical or biological agents, is provided to the patient during the brain scan. The method typically involves at least one pre-dose scan of the subject followed by a waiting period on the order of minutes to hours, thereby performing a second post-dose diagnostic scan. The diagnostic scan may be of conventional nature or of multimodal diversity. Comparisons in the form of differences or ratios between data streams or extracted features from the data stream before and after diagnostic administration represent tones in the subject's brain using molecular specificity. Outcome data may be used to evaluate cases of medical misconduct and can be used for return-to-work decisions regarding brain and soft tissue injuries where decisions have traditionally been subjective in nature It is. [Selection] Figure 2
展开▼
